Associated Papers
The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs.
Gentilini F et al.
Bmc Veterinary Research, 2020
Genetic alterations of KIT during clonal expansion and subsequent acquisition of resistance to toceranib in a canine mast cell tumor cell line.
Kurita S et al.
Journal of Veterinary Pharmacology and Therapeutics, 2019
Select a paper to view details